PharmaCorp Rx (TSXV:PCRX) Beneish M-Score : 0.00 (As of Dec. 15, 2024)

View and export this data going back to 2022. Start your Free Trial

What is PharmaCorp Rx Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for PharmaCorp Rx's Beneish M-Score or its related term are showing as below:

During the past 3 years, the highest Beneish M-Score of PharmaCorp Rx was 0.00. The lowest was 0.00. And the median was 0.00.

PharmaCorp Rx Beneish M-Score Historical Data

The historical data trend for PharmaCorp Rx's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCorp Rx Beneish M-Score Chart

PharmaCorp Rx Annual Data

Trend

Dec21

Dec22

Dec23

Beneish M-Score

PharmaCorp Rx Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beneish M-Score	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of PharmaCorp Rx's Beneish M-Score

For the Shell Companies subindustry, PharmaCorp Rx's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaCorp Rx's Beneish M-Score Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, PharmaCorp Rx's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PharmaCorp Rx's Beneish M-Score falls into.

PharmaCorp Rx Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PharmaCorp Rx for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Sep24) TTM:

Last Year (Sep23) TTM:

Total Receivables was C$0.22 Mil.
Revenue was 1.104 + 0.291 + 0 + 0 = C$1.40 Mil.
Gross Profit was 0.415 + 0.099 + 0 + 0 = C$0.51 Mil.
Total Current Assets was C$27.29 Mil.
Total Assets was C$32.08 Mil.
Property, Plant and Equipment(Net PPE) was C$0.91 Mil.
Depreciation, Depletion and Amortization(DDA) was C$0.10 Mil.
Selling, General, & Admin. Expense(SGA) was C$2.60 Mil.
Total Current Liabilities was C$0.64 Mil.
Long-Term Debt & Capital Lease Obligation was C$0.84 Mil.
Net Income was -0.976 + -0.596 + -0.202 + -0.216 = C$-1.99 Mil.
Non Operating Income was 0.001 + 0 + 0 + 0 = C$0.00 Mil.
Cash Flow from Operations was -0.643 + -0.157 + -0.189 + -0.29 = C$-1.28 Mil.

Total Receivables was C$0.00 Mil.
Revenue was 0 + 0 + 0 + 0 = C$0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = C$0.00 Mil.
Total Current Assets was C$2.53 Mil.
Total Assets was C$2.53 Mil.
Property, Plant and Equipment(Net PPE) was C$0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was C$0.00 Mil.
Selling, General, & Admin. Expense(SGA) was C$0.36 Mil.
Total Current Liabilities was C$0.04 Mil.
Long-Term Debt & Capital Lease Obligation was C$0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.223 / 1.395)	/	(0 / 0)
	=	0.159857	/
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0 / 0)	/	(0.514 / 1.395)
	=		/	0.368459
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (27.293 + 0.91) / 32.079)	/	(1 - (2.532 + 0) / 2.532)
	=	0.120827	/	0
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	1.395	/	0
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0 / (0 + 0))	/	(0.098 / (0.098 + 0.91))
	=		/	0.097222
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(2.604 / 1.395)	/	(0.36 / 0)
	=	1.866667	/
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.841 + 0.64) / 32.079)	/	((0 + 0.041) / 2.532)
	=	0.046167	/	0.016193
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-1.99 - 0.001	-	-1.279)	/	32.079
	=	-0.022195

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PharmaCorp Rx Beneish M-Score Related Terms

Thank you for viewing the detailed overview of PharmaCorp Rx's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCorp Rx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » PharmaCorp Rx Inc (TSXV:PCRX) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1

Website

PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.